Trials / Sponsors / Zhejiang Palo Alto Pharmaceuticals, Inc.
Zhejiang Palo Alto Pharmaceuticals, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy Chronic HBV Infection | Phase 1 | 2023-04-13 |
| Completed | Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patien Chronic HBV Infection | Phase 1 / Phase 2 | 2021-09-17 |
| Completed | Study of the Safety, Tolerability, Pharmacokinetic Characteristics of PA1010 in Healthy Subjects Chronic HBV Infection | Phase 1 | 2020-06-28 |